MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Syntactx Appoints Dr. David Deaton as Chief Medical Officer
February 1, 2017—Syntactx recently announced that David Deaton, MD, has joined the company as Chief Medical Officer.
Sponsored by Medical Metrics, Inc.
The Role of the Core Lab in Pursuit of Clinical Trial Excellence
The selection of a medical imaging core lab can make or break a clinical study.
By David Deaton, MD, FACS; Peter A. Schneider, MD, FACS; N. Shastry Akella, PhD; and Daniel Auger, PhD
Endologix Appoints Prof. Matthew Thompson as Chief Medical Officer
October 25, 2016—Endologix, Inc. announced the appointment of Matthew Thompson, MD, as Chief Medical Officer effective December 2016.
Applying Existing Technologies to Vascular Applications
Examples of how current technologies in wearables, tissue engineering, and imaging and computer simulation could be applied to vascular care in the future.
By David H. Deaton, MD, FACS
Healthcare Inroads Announces Global Launch
March 14, 2024—Healthcare Inroads, LLC, (HCIR) announced its launch as a partnership of clinicians and allied specialists dedicated to accelerating the goals and milestones of medical device companies, investors, and health care systems in the United States, Europe, and Asia.
Provisio Medical Names Physician Advisory Board to Help Guide Commercialization
May 6, 2024—Provisio Medical, Inc. announced the formation of a Physician Advisory Board composed of a multidisciplinary group of physicians who will provide input and feedback on product development decisions, outcome-focused clinical studies, and therapeutic applications of Provisio’s core sonic lumen tomography intravascular ultrasound (SLT IVUS) technology for the treatment of patients with peripheral artery disease.
The Future of Carotid Artery Stenting
Is it Ready for Prime Time?
Elucid Launches PlaqueIQ Image Analysis Software for Carotid Arteries
October 29, 2025—Elucid announced the launch of its PlaqueIQ image analysis software for the quantification and classification of plaque morphology in the carotid arteries.
FDA Clears Aptus HeliFX Securement System
November 21, 2011—Aptus Endosystems, Inc. (Sunnyvale, CA) announced that it received 510(k) clearance from the US Food and Drug Administration for the company's endostapling system, which will now be known as the HeliFX aortic securement system, for use during endovascular aneurysm repair (EVAR).
Aptus' HeliFX Securement System Cleared for TEVAR
September 13, 2012—Aptus Endosystems, Inc. (Sunnyvale, CA) announced 510(k) clearance from the US Food and Drug Administration for its thoracic-length HeliFX aortic securement system for the treatment of thoracic aortic aneurysms (TAAs).
LEOPARD to Compare Endologix AFX System to Other Commercially Available EVAR Devices
September 29, 2014—Endologix, Inc. announced that it will conduct a prospective, randomized clinical trial to compare outcomes in endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs). The company says the LEOPARD trial (Looking at EVAR Outcomes by Primary Analysis of Randomized Data) has been designed to provide an unbiased assessment of commercially available EVAR devices.
Venous Issues
By Barry T. Katzen, MD
The Next Generation of Aortic Endografts
Developing trends and new technologies.
By David H. Deaton, MD
Aptus Endovascular AAA Repair System
Report of the 1-year follow-up in a first-in-man study.
By Takao Ohki, MD; David H. Deaton, MD; and José Antonio Condado, MD
A New Vascular Decade
By Peter A. Schneider, MD
Endologix Appoints David H. Deaton, MD, as Chief Medical Officer
October 15, 2013—Endologix (Irvine, CA) announced that it has appointed David H. Deaton, MD, to the newly created position of Chief Medical Officer, effective immediately.
An Interview With David H. Deaton, MD
A prominent vascular surgeon shares his experiences with AAA devices, the PAD Coalition, and how surgery is a family business.
Aortic Arch Reconstruction
Synergy of open and endovascular techniques.
By David H. Deaton, MD; Yvonne M. Carter, MD; Joseph C. Babrowicz, MD; and Richard F. Neville, MD
Remote Endarterectomy
An old technique comes back to the future.
Endovascular Aortic Reconstruction
Use of Preview software to plan and predict intervention.
By David H. Deaton, MD, and Richard Neville, MD
